The phenotype of myeloid neoplasms may depend on the intensity of signaling on specific downstream targets in the JAK-STAT signaling pathway, which is related to the number of JAK2 V617F copies and the presence of additional gene mutations affecting RNA splicing genes or epigenetic regulators [7]. The gene discussed is SOAT1; the disease is myeloid neoplasm.